AGA American Gastroenterological Association

TASL Türk Karaciğer Araştırmaları Derneği

İç Hastalıkları Uzmanlık Derneği

European Board of Gastroenterology: 2005

TGD yeterlilik belgesi. 2008

American Gastroenterology Fellowship: 2018

 Inhibition of cholecystokinin induced gallbladder contraction by atropine and pirenzepine in man. B.Ç.Yeğen, E.Tankurt, N.Gürmen,Ş.Oktay, N.B.Ulusoy. Digestion 1990;45:176-180

The effect of diltiazem on renal function in patients with liver cirrhosis. N.Tözün, K.Berkman, E.Tankurt, S.Aran, Y.Taga. International Journal of Clinical Pharmacology Therapy and Toxicology 1991;29(5):190-203

Cholecystokinin-induced contractions in the opossum gallbladder. N.B.Ulusoy, Ş.Oktay, B.Ç.Yeğen, E.Tankurt. Gastroenterology 1991;100:847

Influence of pirenzepine on gallbladder contraction in man induced by sham feeding or an intraduodenal meal. E.Tankurt, B.Ç.Yeğen, T.Biren, Ş.Oktay, N.B.Ulusoy. Digestion 1992;51:103-109

Endoscopic removal of swallowed endotracheal tubes from two patients: an unusual complication of coronary by-pass surgery.C.Kalaycı, E.Tankurt, N.Tözün, N.B.Ulusoy. Endoscopy 1994;26:364

Adverse allergic reaction to technettium-99m-Mebrofenine. B.Değirmenci, H.Durak, E.Ellidokuz, E.Tankurt. The Journal of Nuclear Medicine 1994;35:1569

Nasobiliary tube impaction during shock wave lithotripsy of common bile duct stone. E.Tankurt, H.Akbaylar, S.Bora, H.Gülay, İ.Şimşek, Ö.Gönen. Gastrointestinal Endoscopy  1995;41:84

Portal vein thrombosis associated with bladder carcinoma. E.Tankurt, A.Çömlekçi, H.Akbaylar, A.Esen, O.Dicle. American Journal of Gastroenterology 1995;90(3):521-522

Modulation of gallbladder contraction by pirenzepine in humans. B.Ç.Yeğen, T.Biren, F.Onat, E.Tankurt , N.Gürmen, Ş.Oktay, W.Y.Chey, N.B.Ulusoy. American Journal of Gastroenterology 1995;90(9):1489-1494

Severe long-lasting symptoms from doxycycline-induced esophageal injury. E.Tankurt, H.Akbaylar, Y.Yeniçerioğu,İ. Şimşek, Ö.Gönen. Endoscopy 1995;27(8):626

Cholecystokinin-induced gallbladder contraction and muscarinic blockade with pirenzepine in man.N.B.Ulusoy, Ş. Oktay, B.Ç. Yeğen, E. Tankurt ,  N. Gürmen. Digestive Disease and Sciences 1995;40(2):427

The prokinetic effect of domperidone in gallbladder, not upon dopaminergic receptors. E.Tankurt, Ş.Apaydın, E.Ellidokuz, E.İğici, H.Güven, İ.Şimşek, Ö.Gönen. Pharmacological Research 1996;33(3):153-156

Resolving FMF attacks with interferon alpha. E.Tankurt, M.Tunca, H.Akbaylar, Ö.Gönen. British Journal of Rheumatology 1996;35:11:1188

The efficacy of interferon alpha on colchicine-resistant FMF attacks. M.Tunca, E.Tankurt, H.Akbaylar, S.Akar, N.Hızlı, Ö.Gönen. British Journal of Rheumatology 1997;36:1005-1008

Increased serum nitrite and nitrate concentrations in chronic hepatitis. E.Tankurt, G.Kırkalı, M.Özcan. E.Ellidokuz. J Hepatol  1998;29:512-513

Hyperinsulinemia and insulin resistance in non-alcoholic steatohepatitis. E.Tankurt, S.Biberoğlu, E.Ellidokuz, Z.Hekimsoy, H.Akpınar, A.Çömlekçi, A.Okan, Ö.Sağol. J Hepatol 1999;31:963-968

Endoscopic Sphincterotomy in the Management of Biliary Leakage after Partial Hepatectomy. A.Okan, E.Tankurt, H.Astarcıoğlu, C.Aydın, H.Akpınar, İ.Astarcıoğlu. Hepato-Gastroenterology 1999;46:790-791

Mirizzi syndrome: Diagnostic and surgical considerations on 24 cases. S.Karademir, H.Astarcıoğlu, S.Sökmen, K.Atilla, E.Tankurt, H.Akpınar, A.Çoker, I.Astarcıoğlu. Journal of HPB Surgery 2000;7:72-77

Serum Concentrarions of IGF-1 and IGFBP-3 in Patients with Chronic Hepatitis. A.Okan, A.Çömlekçi, H.Akpınar, İ.Okan, S.Yeşil, E.Tankurt, İ.Şimşek. Scan J Gastroenterol 2000;35:1212-1215

Risk factors for hepatocellular carcinoma in Turkey. Uzunalimoğlu Ö, Yurdaydın C, Çetinkaya H, Bozkaya H, Şahin T, Çolakoğlu S, Tankurt E, Özenirler S, Sarıoğlu M, Akkiz H, Tözün N, Değertekin H, Ökten A. Dig Dis Sci 2001; 46 (5):1022-1028

Effect of ursodeoxycholic acid on hepatic steatosis in rats. A.Okan, H.Astarcıoğlu, E.Tankurt, Ö.Sağol, E.Altekin, İ.Astarcıoğlu, Ö.Gönen. Dig Dis Sci 2002, 47:2389-2397

Relationship between non-steroidal anti-inflammatory drug use and Helicobacter pylori infection in bleeding or uncomplicated peptic ulcers:A case control study. A.Okan, E.Tankurt, B.Aslan, H.Akpınar, İ.Şimşek, Ö.Gönen. J Gastroenterol Hepatol 2003;18:18-25

The role of serum leptin levels in chronic hepatitis C with steatosis. E. Ellidokuz, A.Çömlekçi, H.Ellidokuz, H.Akpınar, Ç.Gökçe, E.Tankurt, Ö.Sağol, İ. Şimşek, Ö. Gönen. Hepatogastroenterology 2003 Dec;50 Supl 2.

Serum leptin levels in patients with cirrhosis and chronic hepatitis. A Çömlekçi, H. Akpınar, S. Yeşil, İ.Okan, E. Ellidokuz, A.Okan, G.Ersöz, E.Tankurt, Y. Batur. Scand Gastroenterol 2003 Jul;38(7):779-86

The effect of interferon alpha administration on acute attacks of familial mediterannean fever. M. Tunca, S.Akar, M.Soytürk, G.Kırkalı, H.Resmi, H.Akhunlar, Ö.Gönen, JR.Gallimore, PN Hawkins, E.Tankurt. Clin Exp Rheumatol 2004 Jul-Aug;22:37-40

Diagnostic usefulness of carbohydrate antigen-125 in cancerous and noncancerous peritoneal effusions. T.  Kemer, M. Örmen, F. Kuralay, M. Pehlivan, B. Ünsal, E.Tankurt. Tohoku J Exp Med 2005 Jan;205(1):11-18

Toxic hepatitis associated with paroxetine. O. Çolakoğlu, E. Tankurt, B. Ünsal, F. Ugur, A. Küpelioğlu, Z. Buyraç, Z. Akpınar. Int J Clin Pract 2005 Jul;59(7):861-2

Profylactic use of low-dose, on-demand, intramuscular hepatitis B immunoglobulin and lamuvidine after liver transplantation. S. Karademir, H. Astarcıoğlu, M. Akarsu, S. Özkardesler, D. Özzeybek, A. Sayıner, M. Akan, E. Tankurt, I. Astarcıoğlu. Transplt Proc 2006 Mar;38(2): 579-83

YMDD motif variants in inactive hepatitis B carriers detected by Inno-Lipa HBV DR assay.  M.Akarsu, A Sengönül, E.Tankurt, A. Sayıner, O. Topalak, H. Akpınar, YH Abacıoğlu. J Gastroenterol Hepatol 2006 Dec; 21(12):1783-8

Pegylated interferon Alfa-2b monotherapy and pegylated interferon Alfa-2b plus lamivudine combination therapy for patients with hepatitis B virus E antigen-negative chronic hepatitis B. S. Kaymakoğlu, D. Oğuz, G. Gür, E. Tankurt, G.Ersöz, C. Kalaycı, Y. Çakaloğlu, A. Ökten. Antimicrob Agents Chemoter 2007 Aug;51(8): 3020-2

Plasminogen activator inhibitor-1 and thrombin activatable fibrinolysis inhibitor in non-alcoholic steatohepatitis. Yener S, Akarsu M, Demir T, Akıncı B, Sagol O, Bayraktar F, Ozcan MA, Tankurt E, Yeşil S. J Endocrinol Invest. 2007 Nov; 30(10) 810-9

Hypercalcemia of primary hyperparathyroidism was treated by cinacalcet in a patient with liver cirrhosis.  Akinci B, Comlekci A, Tankurt E.  Exp Clin Endocrinol Diabetes 2009 Mar; 117 (3):142-5

Safety and tolerability of BRAVO capsule pH monitoring. Tankurt E, Tozumay N, Sengul B, Kinik E, Acil B. Turk J Gastroenterol 2011; 22(3):352-3

Esophageal ulcers: a possible adverse effect of isotretionin. Tankurt E., Doğanay L., Yücetürk TE. Turk J Gastroenterol 2013; 24(6):562-3

The prevalence of Helicobacter pylori infection in patients with gastric and duodenal ulcers - a 10-year, single-center experience. Serin A, Tankurt E., Şarkış C., Şimşek İ. Prz gastroenterol 2015;10(3):160-3